NAD+
NAD+ injections and IV drips: what NAD+ is, its FDA status, FDA reports of reactions to food-grade NAD+, and how thin the human evidence is.
Not FDA-approved · Evidence grade C · Reviewed
Not approved by the FDA for human use. Not for human consumption. This page describes NAD+ only to explain its regulatory status, what has been studied and its known risks. Drawline does not recommend obtaining or using it. Disclaimer
Regulatory historyOctober 2024: FDA warned that some pharmacies were making IV NAD+ from food-grade ingredients that are not suitable for sterile products, and reported reactions consistent with bacterial toxins.See every change in the 2026 tracker ›- Not approvedHealthy agingSold as IV drips and injections; not approved
- Not approvedAddiction and withdrawalSmall or uncontrolled studies only
NAD+ (Nicotinamide adenine dinucleotide). Coenzyme (not a peptide).
CNot FDA-approved. Evidence grade C: limited, early or dated human data.
What is NAD+?
NAD+ is a coenzyme found in every cell, involved in energy metabolism and DNA repair. IV drips and injections are sold in wellness clinics for healthy aging, and have been used for addiction and withdrawal.
Is NAD+ FDA-approved?
No FDA-approved NAD+ drug was found. For pharmacy compounding, FDA lists NAD under evaluation. In October 2024 FDA warned that some pharmacies were making IV NAD+ from food-grade ingredients, which are not suitable for sterile products, and reported severe chills, shaking, vomiting and fatigue after NAD+ injections, consistent with bacterial toxins.
What does the evidence show for NAD+?
Mostly small or uncontrolled studies. A 2019 study in 11 healthy men measured how blood levels rise during a slow infusion, with no health outcome. Studies in addiction are old, small or uncontrolled. A 2026 review called the evidence preliminary and insufficient to support routine clinical or wellness use.
What are the known risks of NAD+?
Nausea, stomach cramps, flushing, a fast heart rate and chest tightness during infusions are commonly reported and often make people slow the drip. Reactions to contaminated product are the other main risk. Long-term safety is unknown. Sport: it is not named on the World Anti-Doping Code Prohibited List, but infusions or injections of more than 100 mL in 12 hours are banned at all times, outside hospital treatment, whatever they contain.
How is NAD+ measured?
Usually given as an IV drip or from a vial. For a vial labeled in mg per mL, the Pre-mixed mode converts a prescribed dose into syringe units.
Sources: FDA: use ingredients suitable for sterile compounding (NAD+), October 2024; FDA: bulk drug substances nominated for compounding under section 503A; Grant et al., NAD+ infusion in healthy men (2019); Reyna et al., NAD+ and NR infusions (2026); Review of IV NAD+ in wellness care (2026); Braidy et al., NAD+ in addiction, review (2020); WADA: 2026 Prohibited List. This profile does not recommend any dose or use.
For research and educational use. Not medical advice. Regulatory status changes, so confirm the current position with FDA or a licensed professional.
Keep reading
Spot a mistake or an out-of-date fact? Report an error. We check every report against the sources.